Marietta Investment Partners LLC Biogen Inc. Transaction History

Marietta Investment Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 09, 2018	SELL	$257.52 - $306.91 $807,840 - $962,776	-3,137 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $5,202 - $7,358	20 Added 0.64%	3,137 $859,000
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $30,764 - $34,458	-100 Reduced 3.11%	3,117 $993,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $904,459 - $1.06 Million	3,217	3,217 $1.01 Million

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Marietta Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Marietta Investment Partners LLC with notifications on news.